Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer

The purpose of this study is to construct an auxiliary diagnostic model for breast cancer by methylation markers. The study will collect blood and tissue samples from participants with breast cancer and benign disease for whole-genome methylation sequencing. It will screen methylation markers and develop a methylation auxiliary diagnosis model to distinguish between breast cancer and non-cancer.

NCT Number	NCT06876610
Lead Sponsor	Geneplus-Beijing Co. Ltd. Collaborators: Chinese Academy of Medical Sciences
Conditions	Breast Cancer Screening
Enrollment	200 participants
Start Date	2025-03-15
Primary Completion	2026-08-31 (estimated)
Study Completion	2026-08-31 (estimated)
Updated on ClinicalTrials.gov	2025-03-14